Die neuesten CLSD Reports werden am 2024-03-12 aktualisiert: 202320222021
Clearside Biomedical logo
Clearside Biomedical CLSD
€ 1.25 6.3%

Clearside Biomedical Kennzahlen 2011-2024 | CLSD

Kennzahlen Jährlich Clearside Biomedical

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-3.1 -1.9 248.1 -8.5 -4.4 -0.4 -2.7 -3.7 - - - - -

P/S

12.3 46.7 3.2 19.5 62.9 1198.6 467.3 182.8 - - - - -

EPS

-0.5 -0.6 0.0 -0.4 -0.8 -2.7 -2.3 -2.0 -7.5 -5.9 - - -

EV (Enterprise Value)

122 M 54.4 M 67.8 M 147 M 130 M 48.4 M 171 M 73.4 M 37.4 M 21.2 M 12.9 M - -

EBITDA per Share

-0.4 -0.5 -0.01 -0.38 -0.788 -2.69 -2.3 -1.92 - - - - -

EV/EBITDA

-73.5 -5.8 -3.9 -0.8 -3.2 -4.6 - - - - -

PEG

-0.0 -0.0 -6.79 -0.16 -0.06 0.03 0.15 0.11 - - - - -

P/B

-6.4 5.8 2.5 17.6 12.2 1.5 7.5 1.3 - - - - -

P/CF

-5.6 -4.6 -8.7 -11.7 -5.0 -0.5 -3.1 -4.2 - - - - -

ROE %

204.15 -310.62 0.99 -207.81 -275.79 -350.63 -275.39 -36.12 - - - - -

ROA %

-95.49 -64.22 0.88 -94.24 -114.92 -187.71 -145.64 -30.52 - - - - -

ROCE %

156.13 -285.44 -1.65 -204.67 -190.92 -246.54 -216.53 -31.73 - - - - -

Current Ratio

0.7 1.3 8.7 1.8 2.3 4.1 2.9 15.6 - - - - -

DSO

- - 61.7 - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

1673.3 1781.2 - - - - - - - - - - -

Betriebszyklus

- - 61.7 - - - - - - - - - -

Finanzkreislauf

-1673.3 -1781.2 61.7 - - - - - - - - - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Clearside Biomedical

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.15 -0.15 -0.15 - -0.13 -0.13 -0.13 - -0.08 -0.11 -0.13 - -0.05 -0.13 -0.07 -0.07 -0.17 -0.15 -0.45 -0.68 -0.75 -0.65 -0.62 -0.65 -0.72 -0.54 -0.41 -0.45 -0.28 -0.62 -2.05 -1.95 -1.31 -2.36 -2.07 - - - - - - - - - - - - - - - -

EBITDA per Share

- - -0.12 - -0.11 -0.13 -0.13 - -0.08 -0.1 -0.15 - -0.05 -0.12 -0.06 - -0.16 -0.15 -0.45 - -0.74 -0.65 -0.61 - -0.71 -0.54 -0.4 - -0.26 -0.62 -2.01 - -1.26 -2.32 - - - - - - - - - - - - - - - - -

ROE %

-130.68 -245.00 -459.06 -97.26 -124.64 -109.82 -110.39 -102.18 -129.94 -130.33 -164.47 -126.65 -154.40 -185.21 -170.94 -275.79 -339.65 -382.14 -418.38 -350.63 -336.03 -320.59 -297.26 -275.39 -211.89 -134.15 -76.95 -36.12 -8.50 8.86 30.51 38.11 24.01 14.53 - - - - - - - - - - - - - - - - -

ROA %

-84.98 -72.11 -74.29 -60.67 -78.52 -82.31 -78.22 -65.59 -78.18 -72.92 -81.39 -57.44 -69.00 -80.82 -72.45 -114.92 -152.40 -182.09 -207.60 -187.71 -179.40 -170.57 -157.67 -145.64 -116.33 -77.71 -49.71 -30.52 -43.65 -53.50 -72.78 -66.36 -41.80 -25.30 - - - - - - - - - - - - - - - - -

ROCE %

-116.83 -207.99 -385.22 -91.41 -118.81 -109.94 -110.43 -108.07 -135.82 -136.18 -168.08 -123.53 -180.61 -209.93 -196.86 -244.61 -346.03 -390.38 -428.53 -259.58 -344.54 -328.07 -303.25 -196.53 -203.93 -126.39 -69.93 -22.11 -12.90 3.71 25.03 23.31 23.31 14.10 - - - - - - - - - - - - - - - - -

Current Ratio

0.7 0.9 1.1 1.3 1.5 5.6 8.3 8.7 2.9 3.1 2.6 1.8 1.8 1.8 1.8 1.7 1.7 1.7 1.7 2.1 2.1 2.1 2.1 2.1 2.1 2.1 2.1 6.5 6.5 6.5 6.5 2.0 2.0 2.0 - - - - - - - - - - - - - - - - -

DSO

60.4 - - - 42.2 14.6 1314.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

1205.8 745.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

60.4 - - - 42.2 14.6 1314.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

-1145.5 -745.4 - - 42.2 14.6 1314.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung